Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value.

Addiction (Abingdon, England) - 1 Dec 2012

Mathews Rebecca, Hall Wayne, Carter Adrian

Abstract excerpt

Genetic research on addiction liability and pharmacogenetic research on treatments for addiction have identified some genetic variants associated with disease risk and treatment. Genetic testing for addiction liability and treatment response has not been used widely in clinical practice because most of the genes identified only modestly predict addiction risk or treatment response. However, many of these genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aldehyde Dehydrogenase
Share to Aldehyde Dehydrogenase, Mitochondrial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Confidentiality

Share to Ethics, Medical

Share to Informed Consent

Share to Prejudice

Share to Receptors, Opioid, mu

Share to Substance-Related Disorders

Source

Identifiers

PMID: 22510165
DOI: 10.1111/j.1360-0443.2012.03836.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value.PMID 22510165Read ↗

Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility.Semantic proximity Read ↗

Consumer genetics and addiction susceptibility testing-just what the consumer ordered.Semantic proximity Read ↗

Ethical Guidelines for Genetic Research on Alcohol Addiction and Its Applications.Semantic proximity Read ↗

Direct‐to‐consumer genetic testing: good, bad or benign?Semantic proximity Read ↗

The genetics of nicotine addiction liability: ethical and social policy implications.Semantic proximity Read ↗

State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.Semantic proximity Read ↗

Current Ethical and Legal Issues in Health-Related Direct-To-Consumer Genetic TestingSemantic proximity Read ↗

Regulating direct-to-consumer genetic tests: what is all the fuss about?Semantic proximity Read ↗

Risks of presymptomatic direct-to-consumer genetic testing.Semantic proximity Read ↗

ACOG Committee Opinion No. 409: Direct-to-Consumer Marketing of Genetic TestingSemantic proximity Read ↗

Breaking barriers in the genomics and pharmacogenetics of drug addiction.Semantic proximity Read ↗

The regulation of direct-to-consumer genetic tests.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.